The 100 largest Healthcare companies by market cap, with valuation and cash-flow metrics.
| Ticker | Company | Market cap | P/E | FCF yield |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.06T | 37.6 | 0.6% |
| JNJ | Johnson & Johnson | $624.74B | 23.9 | 3.1% |
| ABBV | AbbVie Inc. | $434.78B | 22.6 | 4.1% |
| UNH | UnitedHealth Group Incorporated | $369.69B | 21.8 | 4.3% |
| MRK | Merck & Co., Inc. | $317.57B | 40.1 | 3.8% |
| NVS | Novartis AG | $297.14B | 18.7 | 5.0% |
| AZN | AstraZeneca PLC | $250.34B | 35.2 | 3.4% |
| AMGN | Amgen Inc. | $222.32B | 18.4 | 3.6% |
| TMO | Thermo Fisher Scientific Inc. | $219.63B | 24.9 | 2.8% |
| NVO | Novo Nordisk A/S | $208.92B | 13.1 | 2.1% |
| ABT | Abbott Laboratories | $186.55B | 20.5 | 3.9% |
| GILD | Gilead Sciences, Inc. | $165.17B | — | 5.7% |
| PFE | Pfizer Inc. | $152.52B | 8.8 | 5.9% |
| DHR | Danaher Corporation | $143.94B | 25.2 | 3.6% |
| ISRG | Intuitive Surgical, Inc. | $135.72B | 37.0 | 1.8% |
| BMY | Bristol-Myers Squibb Company | $132.20B | 9.9 | 9.7% |
| SYK | Stryker Corporation | $130.04B | 24.3 | 3.3% |
| VRTX | Vertex Pharmaceuticals Incorporated | $125.73B | 26.1 | 2.5% |
| CVS | CVS Health Corporation | $122.40B | 12.2 | 6.4% |
| MDT | Medtronic plc | $111.57B | 15.8 | 4.6% |
| GSK | GSK plc | $106.07B | 11.1 | 5.9% |
| SNY | Sanofi | $104.14B | 8.9 | 7.8% |
| MCK | McKesson Corporation | $101.38B | 21.3 | 5.0% |
| HCA | HCA Healthcare, Inc. | $89.49B | 13.9 | 7.8% |
| ELV | Elevance Health, Inc. | $85.49B | 13.4 | 3.6% |
| REGN | Regeneron Pharmaceuticals, Inc. | $80.75B | 16.7 | 4.4% |
| CI | The Cigna Group | $74.65B | 9.0 | 11.1% |
| BSX | Boston Scientific Corporation | $71.46B | 15.4 | 4.6% |
| COR | Cencora, Inc. | $61.15B | 18.7 | 5.1% |
| TAK | Takeda Pharmaceutical Company Limited | $55.73B | 35.2 | 7.3% |
| CAH | Cardinal Health, Inc. | $55.37B | 22.7 | 3.2% |
| ARGX | argenx SE | $53.79B | 33.2 | 1.0% |
| EW | Edwards Lifesciences Corporation | $51.71B | 31.9 | 2.5% |
| BDX | Becton, Dickinson and Company | $48.17B | 13.6 | 5.2% |
| MDLN | Medline Inc. | $47.40B | — | 4.5% |
| NTRA | Natera, Inc. | $46.43B | — | 0.2% |
| HUM | Humana Inc. | $46.23B | 22.4 | 0.8% |
| IDXX | IDEXX Laboratories, Inc. | $46.22B | 41.3 | 2.2% |
| HLN | Haleon plc | $44.17B | 23.3 | 6.6% |
| RVMD | Revolution Medicines, Inc. | $43.97B | — | -2.3% |
| A | Agilent Technologies, Inc. | $41.23B | 25.1 | 2.8% |
| TEVA | Teva Pharmaceutical Industries Limited | $41.20B | 15.4 | 2.8% |
| WAT | Waters Corporation | $39.95B | 29.7 | 2.2% |
| ONC | BeOne Medicines AG | $39.40B | 61.3 | 2.2% |
| IQV | IQVIA Holdings Inc. | $39.29B | 19.1 | 5.0% |
| VEEV | Veeva Systems Inc | $37.44B | 27.7 | 3.7% |
| ALC | Alcon Inc. | $35.02B | 22.6 | 4.5% |
| RPRX | Royalty Pharma plc | $32.80B | 10.8 | 7.8% |
| CNC | Centene Corporation | $32.49B | 12.7 | 13.3% |
| GEHC | GE HealthCare Technologies Inc. | $32.42B | 15.5 | 4.6% |
| DXCM | DexCom, Inc. | $31.98B | 33.2 | 3.1% |
| RMD | ResMed Inc. | $30.74B | 19.0 | 4.1% |
| BIIB | Biogen Inc. | $30.72B | 14.9 | 6.4% |
| ZTS | Zoetis Inc. | $30.02B | 11.0 | 7.1% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $29.33B | 27.5 | 1.6% |
| MTD | Mettler-Toledo International Inc. | $28.64B | 31.9 | 2.9% |
| INSM | Insmed Incorporated | $28.63B | — | -3.7% |
| ILMN | Illumina, Inc. | $28.38B | 36.5 | 3.2% |
| DGX | Quest Diagnostics Incorporated | $26.31B | 22.4 | 5.0% |
| ROIV | Roivant Sciences Ltd. | $26.25B | — | -3.0% |
| PHG | Koninklijke Philips N.V. | $26.13B | 13.7 | 2.2% |
| LH | Labcorp Holdings Inc. | $25.88B | 18.2 | 4.5% |
| WST | West Pharmaceutical Services, Inc. | $24.92B | 41.7 | 1.8% |
| INCY | Incyte Corporation | $24.44B | 13.5 | 5.5% |
| MRNA | Moderna Inc | $23.62B | — | -9.0% |
| BNTX | BioNTech SE | $23.53B | — | -1.5% |
| STE | STERIS plc | $23.14B | 22.8 | 4.2% |
| UTHR | United Therapeutics Corporation | $23.11B | 19.3 | 4.0% |
| GH | Guardant Health, Inc. | $22.61B | — | -1.1% |
| THC | Tenet Healthcare Corporation | $21.11B | 13.6 | 10.6% |
| GMAB | Genmab A/S | $19.49B | 21.1 | 5.8% |
| VTRS | Viatris Inc. | $18.87B | 6.5 | 9.6% |
| ZBH | Zimmer Biomet Holdings, Inc. | $18.42B | 11.4 | 7.4% |
| ASND | Ascendis Pharma A/S | $16.75B | — | 0.3% |
| JAZZ | Jazz Pharmaceuticals plc | $16.65B | 9.6 | 7.3% |
| NBIX | Neurocrine Biosciences, Inc. | $16.61B | 18.5 | 4.5% |
| BBIO | BridgeBio Pharma, Inc. | $16.55B | — | -2.8% |
| MEDP | Medpace Holdings, Inc. | $16.49B | 34.6 | 3.9% |
| COO | The Cooper Companies, Inc. | $14.48B | 16.3 | 2.9% |
| BAX | Baxter International Inc. | $14.24B | 13.4 | 2.3% |
| SOLV | Solventum Corporation | $14.13B | 11.7 | -0.1% |
| EXEL | Exelixis, Inc. | $13.40B | 15.4 | 5.5% |
| FMS | Fresenius Medical Care AG | $12.92B | 10.6 | 14.4% |
| CRL | Charles River Laboratories International, Inc. | $12.88B | 27.0 | 3.9% |
| RVTY | Revvity, Inc. | $12.79B | 21.4 | 3.8% |
| PEN | Penumbra, Inc. | $12.79B | 77.9 | 1.4% |
| ICLR | ICON Public Limited Company | $12.69B | 14.2 | 6.6% |
| SNN | Smith & Nephew plc | $12.62B | 13.3 | 6.5% |
| EHC | Encompass Health Corporation | $12.42B | 21.4 | 3.4% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.38B | — | 1.3% |
| BTSG | BrightSpring Health Services, Inc. | $12.35B | 42.5 | 2.9% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.35B | 25.1 | 5.7% |
| ALGN | Align Technology, Inc. | $12.34B | 15.6 | 3.9% |
| HALO | Halozyme Therapeutics, Inc. | $12.23B | 19.2 | 2.8% |
| CORT | Corcept Therapeutics Incorporated | $11.97B | 263.7 | 1.1% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $11.78B | — | -1.7% |
| DVA | DaVita Inc. | $11.72B | 14.4 | 9.4% |
| ABVX | ABIVAX Société Anonyme | $11.41B | — | -2.0% |
| TECH | Bio-Techne Corporation | $11.26B | 37.3 | 2.2% |
| GMED | Globus Medical, Inc. | $11.18B | 16.7 | 5.1% |